Ron Leuty

Biotech veteran Tassos Gianakakosis planning an IPO for his three-year-old startup after securing a $13B buyout for his last company.

A Peninsula company tries again to win FDA approval of its drug for patients with a rare Cushing syndrome.

'I kind of feel closer to this': Why Alice Zhang predicts AI drug-development success with Verge Labs

A Korean biotech company's Bay Area spinout has launched tests of its theory for beating back cancer.

Lung cancer took tech executive Susan Wojcicki's life. Now her family has started a foundation as a “catalyst for change.”

This pioneering Bay Area company is losing its founding CEO.

Susan Wojcicki was the 16th person hired at Google, as a marketing executive in 1999. She became YouTube's CEO in 2014, eight years after Google bought the company for $1.65 billion in a deal she had championed, and stepped down in February 2023.

Charles Huang delivered a big gift for Chinese Hospital in the early days of Covid. Now the private equity executive's name is on its outpatient center.

This startup backed by Peter Thiel’s Founders Fund wants to reprogram your cells.

With billions of dollars at stake, trio of Bay Area biotechs nail down deals